Quick Answer
MUSTANG BIO, INC. reported Total Assets of $17.59 million for the year ending 2025.
- MUSTANG BIO, INC. showed an increase of +89.0% in Total Assets from 2024 to 2025.
- This data is from MUSTANG BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2016: $11.12 million | Q1 2017: $75.03 million | Q2 2017: $73.84 million | Q3 2017: $67.89 million | Q1 2018: $61.09 million | Q2 2018: $55.68 million | Q3 2018: $49.51 million | Q1 2019: $50.49 million | Q2 2019: $92.63 million | Q3 2019: $83.84 million | Q1 2020: $68.56 million | Q2 2020: $96.83 million | Q3 2020: $86.07 million | Q1 2021: $141.82 million | Q2 2021: $143.21 million | Q3 2021: $134.71 million | Q1 2022: $136.96 million | Q2 2022: $121.91 million | Q3 2022: $108.84 million | Q1 2023: $73.61 million | Q2 2023: $29.09 million | Q3 2023: $20.57 million | Q1 2024: $14.59 million | Q2 2024: $8.52 million | Q3 2024: $7.19 million | Q1 2025: $14.91 million | Q2 2025: $13.05 million | Q3 2025: $19.36 million.
- Historical annual values: Fiscal year 2025: $17.59 million | Fiscal year 2024: $9.31 million | Fiscal year 2023: $17.74 million | Fiscal year 2022: $92.42 million | Fiscal year 2021: $125.17 million | Fiscal year 2020: $109.90 million | Fiscal year 2019: $73.45 million | Fiscal year 2018: $42.75 million | Fiscal year 2017: $63.49 million | Fiscal year 2016: $27.50 million | Fiscal year 2015: $0.00.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: